Products
Companies
News
About
About
FAQ
Contact
Contact
Newsletter
×
Subscribe to our monthly newsletter
Subscribe
Products
e-MRI
e-MRI
Brainomix
Brainomix 360 e-MRI provides both viewing and analysis capabilities for imaging datasets acquired with MRI including Perfusion Weighted Imaging (PWI) and Diffusion Weighted Imaging (DWI). The DWI MRI analysis capabilities are used to visualize local water diffusion properties from the analysis of diffusionweighted MRI data. The MRI PWI analysis capabilities are for visualization and analysis of dynamic imaging data, showing properties of changes in contrast over time. This functionality includes calculation of parameters related to tissue flow (perfusion) and tissue blood volume.
Information source:
Vendor
Last updated:
February 18, 2024
General Information
Technical Specifications
Regulatory
Market
Evidence
General Information
General
Product name
e-MRI
Company
Brainomix
Subspeciality
Neuro
Modality
MR
Disease targeted
Stroke
Key-features
Visualization and analysis of dynamic imaging data, showing properties of changes in contrast over time, e.g. tissue flow (perfusion) and tissue blood volume (rCBF, rCBV, MTT, Tmax, TTP, ADC, isoDWI, Trace, FLAIR)
Suggested use
Technical Specifications
Data characteristics
Population
Patients with suspicion of stroke
Input
MRI including Perfusion Weighted Imaging (PWI) and Diffusion Weighted Imaging (DWI)
Input format
DICOM
Output
Heatmaps and segmentation outlines, clinical scoring
Output format
Technology
Integration
Integration in standard reading environment (PACS), Stand-alone third party application, Stand-alone webbased
Deployment
Locally on dedicated hardware, Locally virtualized (virtual machine, docker), Cloud-based, Hybrid solution
Trigger for analysis
Automatically, right after the image acquisition, On demand, triggered by a user through e.g. a button click, image upload, etc.
Processing time
Regulatory
Certification
CE
No or not yet,
FDA
510(k) cleared , Class II
Intended Use Statements
Intended use (according to CE)
Market
Market presence
On market since
08-2023
Distribution channels
Countries present (clinical, non-research use)
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing
Pricing model
Based on
Evidence
Evidence
Peer reviewed papers on performance
Automated Assessment of DWI-FLAIR Mismatch in Patients with Acute Ischemic Stroke: Added Value to Routine Clinical Practice
(read)
Non-peer reviewed papers on performance
Other relevant papers